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In 1970, a kinase activity that phosphorylated a minor species of
seryl-tRNA to form phosphoseryl-tRNA was found in rooster liver
[Maenpaa, P. H. & Bernfield, M. R. (1970) Proc. Natl. Acad. Sci. USA
67, 688–695], and a minor seryl-tRNA that decoded the nonsense
UGA was detected in bovine liver. The phosphoseryl-tRNA and the
minor UGA-decoding seryl-tRNA were subsequently identified as
selenocysteine (Sec) tRNA[Ser]Sec, but the kinase activity remained
elusive. Herein, by using a comparative genomics approach that
searched completely sequenced archaeal genomes for a kinase-like
protein with a pattern of occurrence similar to that of components
of Sec insertion machinery, we detected a candidate gene for
mammalian phosphoseryl-tRNA[Ser]Sec kinase (pstk). Mouse pstk
was cloned, and the gene product (PSTK) was expressed and
characterized. PSTK specifically phosphorylated the seryl moiety
on seryl-tRNA[Ser]Sec and, in addition, had a requirement for ATP
and Mg2. Proteins with homology to mammalian PSTK occur in
Drosophila, Caenorhabditis elegans, Methanopyrus kandleri, and
Methanococcus jannaschii, suggesting a conservation of its func-
tion across archaea and eukaryotes that synthesize selenoproteins
and the absence of this function in bacteria, plants, and yeast. The
fact that PSTK has been highly conserved in evolution suggests
that it plays an important role in selenoprotein biosynthesis andor
regulation.
Selenocysteine (Sec) has its own code word, UGA, and its owntRNA, and therefore is viewed as the 21st amino acid in the
genetic code (reviewed in refs. 1–4). Although UGA usually
codes for the termination of protein synthesis, it also specifies
Sec if specific requirements are met. The presence of a stem–
loop structure downstream of UGA, called a Sec insertion
sequence (SECIS) element, is the critical component in seleno-
protein mRNAs that dictates UGA to code for Sec (reviewed in
ref. 5). In mammals, the SECIS element occurs in the 3
untranslated region of selenoprotein mRNAs. A specific elon-
gation factor, EFsec, specifically recognizes selenocysteyl-
tRNA[Ser]Sec (6, 7), and a SECIS element binding protein, SBP2,
binds specifically to the SECIS element (8), directing the inser-
tion of Sec into protein in response to UGA.
It has been known for several years that the biosynthesis of Sec
occurs on its tRNA in both bacteria (9) and mammals (10) after
the tRNA is initially aminoacylated with serine by seryl-tRNA
synthetase. In Escherichia coli, the pathway for the biosynthesis
of Sec has been completely established (reviewed in ref. 1). After
the aminoacylation of bacterial tRNA[Ser]Sec with serine, the
hydroxyl group is removed from the seryl moiety to yield an
aminoacrylyl intermediate, and this step is catalyzed by a pyri-
doxal phosphate-dependent Sec synthase. The aminoacrylyl
intermediate serves as the acceptor for the activated selenium
donor, monoselenophosphate, which is synthesized from selenite
and ATP in the presence of selenophosphate synthetase (re-
viewed in ref. 1). Once selenium is donated to the intermediate,
the biosynthesis of Sec on tRNA[Ser]Sec is complete.
In eukaryotes, however, the biosynthesis of Sec has not been
established, but several components have been identified over
the years that play a role in this process. For example, in 1970,
a minor seryl-tRNA was reported to form phosphoseryl-tRNA
by a kinase activity from rooster liver (11), and a minor
seryl-tRNA from bovine, rabbit, and chicken livers was reported
to specifically decode the nonsense codon UGA (12). Although
it was subsequently shown that both the minor seryl-tRNA that
formed phosphoseryl-tRNA and the one that decoded UGA
were the same tRNA (13), it was not known at the time these
components were discovered that they played instrumental roles
in the biosynthesis of Sec and its incorporation into protein as the
21st amino acid in the genetic code. The minor serine tRNA was
subsequently found to be selenocysteyl-tRNA[Ser]Sec (10), but the
role of the putative kinase that phosphorylated seryl-
tRNA[Ser]Sec has not been resolved. Higher vertebrates contain
two Sec tRNA[Ser]Sec isoforms that differ from each other by a
single methyl group that occurs at the 2-hydroxyl of ribose in the
wobble position of the anticodon. One isoform, containing
5-methylcarboxymethyluridine (mcm5U), is the precursor of the
other, which contains 5-methylcarboxymethyluridine-2-O-
methylribose (mcm5Um) (reviewed in ref. 2).
In the present study, a computational search of several
archaeal and eukaryotic genomes for the presence of a kinase-
like gene that occurred in those organisms containing the Sec
insertion machinery but not in those organisms lacking this
machinery revealed a candidate phosphoseryl-tRNA[Ser]Sec ki-
nase gene (designated pstk). The pstk gene product (PSTK) was
expressed and characterized. It indeed specifically phosphory-
lates seryl-tRNA[Ser]Sec. These and other properties of PSTK are
reported herein.
Methods
Materials. Selenium-75 (specific activity 1,000 Cimmol; 1 Ci 
37 GBq) was obtained from the Research Reactor Facility,
University of Missouri, Columbia. [-32P]ATP (specific activity
6,000 Cimmol), [-32P]ATP (specific activity 3,000 Ci
mmol), and [3H]serine (specific activity 29 Cimmol) were
obtained from Amersham Biosciences. The following were
purchased: Ni-NTA (nitrilotriacetate) agarose from Qiagen
(Valencia, CA); Pfu DNA polymerase and pBluescript II from
Stratagene; the pET-16b expression vector, the pET-32b vector
(encoding 109-aa thioredoxin with a His-tag), and BL21(DE3)
competent cells from Novagen; polynucleotide kinase and Nu-
PAGE Bis-Tris gels from Invitrogen; alkaline phosphatase from
New England Biolabs; T7 RiboMAX Express Large Scale RNA
Production Systems and Wizard Genomic DNA Purification Kit
from Promega; and puReTaq Ready-To-Go PCR Beads and
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Hybond-N nylon membranes from Amersham Biosciences.
Mung bean nuclease was purchased from New England Biolabs,
and P81 phosphocellulose filter paper (catalog no. 3698325) was
purchased from Whatman. I.M.A.G.E. Consortium Clone ID
654975 encoding pstk was obtained from the American Type
Culture Collection. All other reagents were commercial prod-
ucts of the highest grade available.
Computational Search for a Candidate PSTK. The strategy to search
for the Sec kinase was to identify all predicted proteins in the
Methanopyrus kandleri genome for which close homologs were
present in Methanococcus jannaschii but were absent in 12 other
completely sequenced archaeal genomes that did not code for
Sec insertion machinery (Aeropyrum pernix, Archaeoglobus fulgi-
dus, Halobacterium, Methanobacterium thermoautotrophicum,
Pyrobaculum aerophilum, Pyrococcus abyssi, Pyrococcus furiosus,
Pyrococcus horikoshii, Sulfolobus solfataricus, Sulfolobus toko-
daii, Thermoplasma acidophilum, and Thermoplasma volca-
nium). To achieve this goal, each of the 1,687 annotated Meth-
anopyrus kandleri proteins was searched against complete,
annotated archaeal proteomes with the BLASTP program. A
candidate protein was considered to have a close homolog in the
genome if two criteria were satisfied for this protein: (i) a hit with
an E-value below 1012 was obtained and (ii) when this protein
hit was searched against a full set of predicted Methanopyrus
kandleri proteins, the closest homolog was either the original
Methanopyrus kandleri protein or the protein that, when com-
pared with the original protein by using the National Center for
Biotechnology Information BL2SEQ program, had an E-value
below 1020. By using this algorithm, 27 candidate ORFs were
identified, which were further screened for homology to known
kinase domains and proteins annotated in the National Center
for Biotechnology Information nonredundant database as ki-
nases. This analysis resulted in two proteins (gi: 20093704 and
20095115), which were further analyzed for the presence of
homologs in completely sequenced eukaryotic genomes. Only
the protein annotated as ‘‘predicted nucleotide kinase’’ (gi:
20095115) had homologs in eukaryotes. Furthermore, these
homologs were present in organisms with a functional Sec
insertion system and were absent in eukaryotes lacking this
system.
Cloning, Expression, and Purification of PSTK. pstk cDNA was am-
plified by using Pfu DNA polymerase and a forward primer,
5-GGGAATTCCATATGGACTACAAGGACGACGATGA-
CAAAATGAAGACCGCGGCGGCTCGTG-3, to generate
seven bases missing at the amino terminus (underlined bases), an
immediate upstream Flag-tag (bolded bases), and an NdeI
restriction site (italicized bases). A reverse primer, 5-
CGCGGATCCTTAATGTTGCTTTGAAAAATACTTC, was
used to generate a BamHI restriction site (italicized bases)
immediately downstream of the termination signal (italicized
and underlined bases) at the carboxyl terminus. The resulting
product was cloned into the pET-16b vector at the NdeI–BamHI
cloning site in which the vector contained a His-tag immediately
upstream of, and in-frame with, the Flag-tag and the pstk ORF.
The sequence of the cDNA construct was confirmed by sequenc-
ing the product generated from the T7 promoter and T7
termination primers encoded in the pET-16b vector. BL21(DE3)
cells were transformed with the construct. For expressing PSTK,
a colony was inoculated in 200 ml of LB containing 100 gml
ampicillin. When the OD600 of the culture reached 0.6, 0.5 mM
isopropyl -D-thiogalactoside was added and expression was
induced for 4 h. The cells were harvested and Ni-NTA agarose
was used to purify PSTK in its native condition, according to the
vendor’s instructions. PSTK was eluted, dialyzed against 1
PBS, and stored at 20°C in 50% glycerol.
Isolation, Aminoacylation, and Fractionation of Natural and Synthetic
tRNA. Total tRNA was isolated from bovine liver and then
aminoacylated with 20 unlabeled amino acids or 19 unlabeled
amino acids and [3H]serine in the presence of a fresh preparation
of rabbit reticulocyte aminoacyl-tRNA synthetases containing
all 20 active synthetases (14). The resulting aminoacyl-tRNAs
were fractionated on an RPC-5 column (15) and tRNA was
precipitated from individual fractions and collected as described
in ref. 14. Both Sec tRNA[Ser]Sec isoforms and serine tRNA1
Ser
were purified to homogeneity, as described in ref. 16. The
32P-labeled probe used in detecting seryl-tRNA[Ser]Sec or
tRNA[Ser]Sec is described in ref. 17. Synthetic tRNA[Ser]Sec was
prepared from the pBluescript II expression vector that encoded
the mouse Sec tRNA[Ser]Sec gene. The gene had been amplified
by using a PCR and then cloned into the vector. The 3 end of
the Sec tRNA[Ser]Sec gene was cut with HindIII and blunt-ended
with mung bean nuclease, Sec tRNA[Ser]Sec was transcribed by
using the T7 RiboMAX Express Large Scale RNA Production
System, and the resulting product was purified according to the
manufacturer’s instructions. The 5 triphosphate that was
present on synthetic tRNA[Ser]Sec was removed by incubation of
the freshly synthesized RNA with alkaline phosphatase and
isolation of tRNA[Ser]Sec after extraction with phenol and pre-
cipitation in ethanol (16).
PSTK Assay. Total aminoacyl-tRNA, fractionated aminoacyl-
tRNAs, purified seryl-tRNAmcmU
[Ser]Sec, purified seryl-tRNAmcmUm
[Ser]Sec ,
synthetic seryl-tRNA[Ser]Sec, or purified seryl-tRNA1
Ser was used
as a substrate for PSTK in 50 l of reaction mixture [20 mM
TrisHCl (pH 7.4)0.01 mM EGTA1 mM DTT10 mM
MgCl250 M ATP1 l of [-32P]ATP (final specific activity
600 Cimmol)0.5 g of pure PSTK]. Coupled aminoacyla-
tion–phosphorylation reactions involved the same components
plus rabbit reticulocyte aminoacyl-tRNA synthetases (14). Re-
actions were incubated for 20 min or at time intervals designated
in figures at 30°C and were spotted on P81 phosphocellulose
filter paper. The filters were washed four times with 0.75%
phosphoric acid (50 ml per wash) and dried, and radio-
activity was measured in a liquid scintillation counter.
[32P]Phospho[3H]seryl-tRNA was deacylated, and the products
were identified as described in ref. 13. The phosphorylated
adenosine product of the kinase reaction was identified by using
[-32P]ATP and analyzing the 32P-labeled product by TLC. The
reversibility of PSTK was assessed by assaying aliquots as
described above in reactions with and without ADP. The level of
-32P-labeled ATP generated from ADP and O-[32P]phos-
phoseryl-tRNA[Ser]Sec at the end of the incubation period and the
amount of remaining O-[32P]phosphoserine (after deacylation of
O-[32P]phosphoseryl-tRNA[Ser]Sec) were determined by analyz-
ing the 32P counts in the products ([-32P]ATP and O-[32P]phos-
phoserine) by cutting out filter strips after TLC (18).
Binding of tRNA to PSTK. PSTK or thioredoxin containing a
His-tag, which was used as a control protein, was added in a total
volume of 100 l containing reaction mixture (see above) with
or without 50 M unlabeled ATP and 500 ng of a highly purified
sample of a mixture of both tRNA[Ser]Sec isoforms or highly
purified tRNAmcmU
[Ser]Sec, tRNAmcmUm
[Ser]Sec , tRNA1
Ser, or synthetic
tRNA[Ser]Sec for 30 min at room temperature. Ni-NTA agarose
(20 l) was added to pull down PSTK or the control protein.
After washing three times with 1 ml of 1 TBS0.1% Tween, the
beads were suspended in 40 l of TBE-urea loading buffer (90
mM Tris64.6 mM boric acid2.5 mM EDTA3.5 M urea, pH
8.3), and 5 l of each sample was loaded onto a 15% TBE-urea
gel. After electrophoresis and transfer of the RNA to a nylon
membrane, RNA was detected by Northern blotting with the
appropriate probe (17).
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PSTK Antibodies. Polyclonal antibodies against PSTK were gen-
erated in rabbits by Spring Valley Laboratories (Woodbine,
MD) by using a peptide encoding a conjugated predicted
amino-terminal epitope region (GATRRDGQPKLGLC-OH)
as antigen.
Results
Computational Search for a Sec Kinase. The requirements for Sec
biosynthesis appear to be similar in eukaryotes and archaea in
regard to the location of SECIS elements in the 3 untranslated
region and the separation of functions for SECIS binding and Sec
insertion in separate proteins in these organisms (2–4). In
contrast, in bacteria, the SECIS elements are located immedi-
ately downstream of the UGA Sec codon, and SECIS binding
and Sec insertion functions are carried out by a single protein,
designated SelB (1). We therefore hypothesized that the forma-
tion of phosphoserine on Sec tRNA might also be conserved
between eukaryotes and archaea.
To test this hypothesis, we attempted to identify a putative
kinase-like protein that is encoded in Methanopyrus kandleri and
Methanococcus jannaschii genomes, the two archaea that encode
the Sec insertion machinery (19, 20), but is absent in 12 other
completely sequenced archaeal genomes that do not code for the
Sec insertion machinery. The search, performed as described in
Methods, yielded only 27 predicted ORFs common to Meth-
anopyrus kandleri and Methanococcus jannaschii genomes and
absent in other archaeal genomes. Of these, two proteins were
homologous to kinases and were annotated as ‘‘predicted sugar
kinase’’ (gi: 20093704) and ‘‘predicted nucleotide kinase’’ (gi:
20095115). The first protein had no homologs in eukaryotes and
thus could not be a Sec kinase common to archaea and eu-
karyotes. The second protein had homologs in several eukary-
otic organisms but no homologs in bacteria. Interestingly, the
occurrence of homologs in eukaryotes closely matched the
presence of known components of eukaryotic Sec insertion
machinery (selenophosphate synthetase, SBP2, and EFSec). For
example, the kinase homologs were present in C. elegans,
Drosophila, and mammals, which are known to have selenopro-
teins, but were absent in yeast and higher plants, which do not
synthesize selenoproteins and lack the components of the Sec
insertion machinery.
The predicted protein sequences of the candidate mouse and
human PSTKs are shown in Fig. 1 and are compared to orthologs
in Drosophila, C. elegans, and the archaea Methanopyrus kandleri
and Methanococcus jannaschii. The mouse and human PSTKs
have 80% identity. The predicted ATP-binding domain appears
to be located at residues 25–32, and it has a high degree of
homology in each organism, as shown in Fig. 1.
Sequence of pstk. The I.M.A.G.E. Consortium Clone ID 6654975
was sequenced and found to contain the complete coding
sequence of pstk, with the exception of seven bases at the amino
terminus. As described in Methods, the missing bases were
inserted at the 5 end (Fig. 2A). The pstk coding sequence is 1,080
nucleotides in length and encodes a 359-aa protein.
Expression and Isolation of PSTK. PSTK, after its expression and
purification (see Methods), was run on a denaturing gel, and,
after electrophoresis, the gel was either stained with Coomassie
blue (Fig. 2B, lane 1) or exposed to antibodies generated against
an amino-terminal peptide of mouse PSTK (Fig. 2B, lane 2).
This highly purified sample of PSTK was used for subsequent
characterization.
PSTK Activity. The rates of aminoacylation of tRNA[Ser]Sec and
phosphorylation of seryl-tRNA[Ser]Sec as independent reactions
and as a coupled reaction are shown in Fig. 3 A and B,
respectively. The aminoacylation of tRNA[Ser]Sec proceeded
slowly and reached a maximal level at 4 min, and then the
seryl-tRNA[Ser]Sec product began to deacylate. The rapid decline
in product was most certainly due to the amount of ATP used in
reaction mixtures, which was much lower than that previously
used in generating seryl-tRNA[Ser]Sec with mammalian seryl-
tRNA synthetases (14). Phosphorylation of seryl-tRNA[Ser]Sec
occurred rapidly and reached a plateau in 3–4 min (Fig. 3A).
As expected, in the coupled reaction, the rate of phosphorylation
depended on the rate of aminoacylation. The coupled reaction
initially proceeded rapidly, and then phosphorylation occurred
Fig. 1. Alignment of PSTK sequences. Accession numbers for PSTK sequences are as follows: Mouse, XP133874; human, NP699167; C. elegans, CAB11556;
Drosophila, NP788937; Methanococcus jannaschii, NP248546; and Methanopyrus kandleri, NP614962. Consensus PSTK sequence is shown below the alignment.
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more slowly over the course of the reaction period (Fig. 3B). The
data demonstrated that the candidate PSTK phosphorylated
seryl-tRNA[Ser]Sec.
Several divalent cations were examined to assess their
requirement for kinase activity (Fig. 3C). Although there was
no activity at 0.01 mM with any of the three divalent cations
examined, a small amount of activity occurred at 0.1 mM. At
higher levels, Mg2 was found to be essential for PSTK activity,
and the maximal activity level occurred at 1.0 mM. Mn2 could
replace Mg2 as a divalent metal cation, but it was not as
efficient as Mg2.
To examine the reversibility of the kinase reaction,
O-[32P]phosphoseryl-tRNA[Ser]Sec was incubated in a mixture
with Mg2 and PSTK and with or without 50 M ADP, and the
loss of 32P was monitored over a 20-min period (Fig. 3D). In the
absence of ADP, 18% of the total O-phosphoseryl-
tRNA[Ser]Sec was lost, whereas 45% was lost in the presence of
ADP. These data suggest that 30% of O-phosphoseryl-
tRNA[Ser]Sec was converted to seryl-tRNA[Ser]Sec and ATP during
the course of the reaction. This result was confirmed by deter-
mining the 32P radioactivity present in these two components at
the end of the incubation period (Fig. 3D). Comparison of the
reversibility of the aminoacylation and phosphorylation reac-
tions suggests that attachment of the phosphate moiety to serine
enhances the stability of this aminoacyl group on tRNA[Ser]Sec.
PSTK Reaction Products. As shown above, the starting components
in the PSTK reaction are seryl-tRNA[Ser]Ser, ATP, and Mg2.
However, it was important to also determine the products in the
reaction. Clearly, the -phosphate group on ATP was trans-
ferred to seryl-tRNA[Ser]Sec to yield O-phosphoseryl-
tRNA[Ser]Sec. To verify that the adenosine phosphate product is
ADP, we used [-32P]ATP as a substrate in place of [-32P]ATP
and identified the adenosine phosphate product as ADP by TLC
(see Methods; data not shown).
Furthermore, deacylation of [32P]phospho[3H]seryl-tRNA[Ser]Sec
and chromatography of the resulting amino acid before and after
treatment with alkaline phosphatase demonstrated that the deacy-
lated product migrated with O-phosphoserine, whereas the alkaline
phosphatase-treated products migrated with inorganic phosphate
(32P) and serine (3H) (data not shown).
Because tRNA[Ser]Sec is the only known tRNA to begin
transcription within the coding sequence (2) and therefore has
a 5 triphosphate, we examined whether the presence or absence
of the 5 triphosphate had any effect on PSTK activity and
whether PSTK could possibly replace a phosphate group at the
5 end. The presence or absence of the 5 triphosphate had no
effect on PSTK activity, and PSTK did not replace the 5
phosphate group (data not shown).
PSTK Specificity. To determine the specificity of PSTK, total
aminoacyl-tRNA was fractionated on an RPC-5 column as
shown in Fig. 4. The two major Sec tRNA[Ser]Sec isoforms are
known to be hydrophobic and elute late from the column (see
ref. 17 and references therein). Their elution in the latter portion
of the column run was confirmed by assaying individual fractions
with a 32P-labeled probe that specifically recognized Sec
tRNA[Ser]Sec. Both isoforms eluted within column fractions 50
and 72. Assay of the column fractions with PSTK and
[-32P]ATP demonstrated that only the two Sec tRNA[Ser]Sec
Fig. 2. Sequence and expression of pstk. (A) Nucleotide sequence. The cloned pstk sequence is shown. The ATG initiation and TAA termination codons are
indicated in bold. (B) Expression of PSTK in bacteria. Lane 1 shows Coomassie-blue-stained gel, and lane 2 shows Western blotting. PSTK was expressed in E. coli
cells as a His-tagged protein; the recombinant protein was isolated and probed with polyclonal antibodies against the amino-terminal peptide of PSTK.
Fig. 3. PSTK activity. (A) Aminoacylation and phosphorylation as independent reactions. Aminoacylation of synthetic tRNA[Ser]Sec with [3H]serine and
phosphorylation of [3H]seryl-tRNA[Ser]Sec with [-32P]ATP were carried out. (B) Aminoacylation and phosphorylation as coupled reactions. Coupled reactions in
which aminoacylation and phosphorylation occurred in the same reaction with [3H]serine and [-32P]ATP were carried out. Use of thioredoxin as a control protein
in place of PSTK in the kinase reaction showed no phosphorylation activity of tRNA[Ser]Sec. (C) Divalent metal cation requirement. Reactions for determining the
cofactor requirement were carried out with increasing concentrations of divalent cation. (D) Reversibility of the reaction. Aliquots were removed from reactions
with or without ADP, and the amount of radioactivity remaining in O-[32P]phosphoseryl-tRNA[Ser]Sec was determined by the phosphocellulose filter assay at the
time intervals shown. At the end of the reaction, the remaining sample was deacylated, and the radioactivity present in ATP and in O-phosphoserine was
determined by measuring strips that were cut out from a developed TLC chromatogram. The reaction was reversed 26.6%, as determined by the radioactivity
present in ATP (8.25  104 cpm) divided by the total counts present in ATP and O-phosphoserine (3.105  105 cpm). Details of the reactions involving
aminoacylation, phosphorylation, cofactor requirement, and reversibility are given in Methods.
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isoforms became labeled, providing strong evidence that the
kinase is specific for these tRNAs. In addition, seryl-tRNA1
Ser
did not serve as a substrate for PSTK.
Binding of Acylated and Unacylated tRNA[Ser]Sec to PSTK. The ability
of tRNA[Ser]Sec, seryl-tRNA[Ser]Sec, and phosphoseryl-tRNA[Ser]Sec
to bind to PSTK in the presence or absence of ATP was examined
(Fig. 5A) by Northern-blot analysis of the tRNA with the appro-
priate labeled tRNA probes. Thioredoxin was used as a control
protein in the binding assay. Synthetic seryl-tRNA[Ser]Sec bound to
PSTK (lane 2), but addition of ATP to the reaction, which resulted
in the formation of O-phosphoseryl-tRNA[Ser]Sec, reduced the
binding (lane 3). The double bands observed in lanes 2 and 3 most
likely represent acylated and unacylated tRNA[Ser]Sec. Synthetic
tRNA[Ser]Sec also bound to PSTK, and the binding appeared to be
enhanced by the addition of ATP (compare lanes 5 and 6). A
mixture of seryl-tRNAmcmU
[Ser]Sec and seryl-tRNAmcmUm
[Ser]Sec bound to
PSTK, but when ATP was added to the reaction the amount of
tRNA binding was reduced (compare lanes 8 and 9), as was
observed with synthetic seryl-tRNA[Ser]Sec (see lanes 2 and 3).
Purified tRNAmcmU
[Ser]Sec and tRNAmcmUm
[Ser]Sec also bound (lanes 11 and 12,
respectively), but the former isoform appeared to bind more
efficiently. tRNA1
Ser did not bind to PSTK (data not shown). Neither
the naturally occurring isoforms nor the synthetic form bound to the
control protein (lanes 1, 4, 7, and 10).
Because tRNA[Ser]Sec bound to PSTK, we examined how
efficiently unacylated tRNA[Ser]Sec inhibited the kinase reaction
(Fig. 5B). Phosphorylation of the seryl moiety was dramatically
inhibited by increasing the amount of unacylated tRNA[Ser]Sec in
the reaction, suggesting that tRNA[Ser]Sec was indeed a potent
inhibitor of the reaction. The fact that tRNA[Ser]Sec is a potent
inhibitor of the kinase reaction precluded the determination of
the Km or affinity constant for the two isoforms.
Discussion
PSTK was originally discovered 30 years ago when a kinase
activity was detected in rooster liver that catalyzed the formation
of phosphoseryl-tRNA on a minor isoform of the total seryl-
tRNA population (11). Since this original report, the identity,
isolation, and cellular role of PSTK, as well as phosphoseryl-
tRNA[Ser]Sec, have remained largely obscure. The minor phos-
phoseryl-tRNA and another minor seryl-tRNA identified in
bovine, rabbit, and chicken livers that decoded the stop codon
UGA (12) were shown to be Sec tRNA[Ser]Sec (13). It was
subsequently reported that phosphoseryl-tRNA[Ser]Sec was the
intermediate in the biosynthesis of Sec in mammals (21, 22) and
in bacteria (23). However, after the identification of aminoacryl-
tRNA[Ser]Sec as the correct intermediate in bacteria (reviewed in
ref. 1), it was reported that phosphoseryl-tRNA[Ser]Sec was not an
intermediate in Sec biosynthesis in mammals and that Sec
biosynthesis proceeded by the same pathway as that in bacteria
(24, 25). The intermediate in the latter studies, however, was not
identified, nor was phosphoseryl-tRNA[Ser]Sec ruled out as a
possible intermediate. Thus, the biosynthesis of Sec in mamma-
lian cells and the role of phosphoseryl-tRNA[Ser]Sec have not
been resolved. It should be noted that the identity elements in
Sec tRNA[Ser]Sec for PSTK have been identified and found to
reside primarily in the secondary structure and length of the
D-stem (26).
In the present study, PSTK was identified by using an algo-
rithm that searched for a kinase-like protein gene in the genomes
of archaea that are known to encode the Sec insertion machinery
vs. those that do not and then comparing the purported kinase
gene sequences to genes manifesting homology in eukaryotes
that do and do not contain the Sec insertion machinery. The
single candidate gene that was found in the genomes of two
archaea and in eukaryotes containing the ability to insert Sec
into proteins, but not in those that do not, was further charac-
terized. After its expression in bacteria, it was isolated as a pure
protein, and in vitro assays confirmed that this purported kinase
was indeed PSTK. PSTK was found to be specific for seryl-
tRNA[Ser]Sec, whereas no activity with other tRNAs was detected.
Fig. 4. Specificity of PSTK. Total calf liver tRNA that had been aminoacylated
with all 20 unlabeled amino acids in the presence of rabbit reticulocyte
synthetases was fractionated on an RPC-5 column (total of 150 A260 units). The
aminoacyl-tRNAs in individual fractions were precipitated, the precipitants
were collected and redissolved, and an aliquot was spotted on a nitrocellulose
filter and hybridized with a specific Sec tRNA[Ser]Sec probe or added to a
reaction containing PSTK and the components for measuring kinase activity.
Arbitrary units represent either the 32P determined in the kinase reaction by
measuring radioactivity of samples in a scintillation counter (e.g., 10,000
cpm  10,000 arbitrary units) or the PhosphorImager units measured with
32P-labeled probe in a PhosphorImager (Molecular Dynamics) (e.g., 10,000
PhosphorImager units  400 arbitrary units).
Fig. 5. Interaction of tRNA[Ser]Sec and PSTK. (A) Binding of tRNA[Ser]Sec to PSTK. Synthetic seryl-tRNA[Ser]Sec was used in lanes 1–3, synthetic tRNA[Ser]Sec in lanes
3–6, a mixture of both naturally occurring seryl-tRNA[Ser]Sec isoforms in lanes 7–9, a mixture of both naturally occurring tRNA[Ser]Sec isoforms in lane 10, tRNAmcmUm
[Ser]Sec
in lane 11, and tRNAmcmU
[Ser]Sec in lane 12. The control protein was thioredoxin. Reaction mixtures were incubated, the proteins were pulled down with Ni-NTA
agarose, and Northern blots were prepared as described in Methods. Each reaction was carried out at least three times, yielding similar results, and representative
samples are shown. (B) Effect of tRNA[Ser]Sec on phosphorylation. Synthetic [3H]seryl-tRNA[Ser]Sec (2 g) was added to PSTK reactions with increasing concentrations
of synthetic tRNA[Ser]Sec as indicated. The percent aminoacylation used in reactions was 62%, and this amount of unacylated tRNA[Ser]Sec (0.76 g) was taken into
account, as indicated in the initial reaction.
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PSTK catalyzed the formation of phosphoseryl-tRNA[Ser]Sec
from seryl-tRNA[Ser]Sec and ATP in the presence of Mg2.
Although Mn2 can also serve as a divalent metal cation for the
reaction, it was not as effective as Mg2. The products were
identified as O-phosphoseryl-tRNA[Ser]Sec and ADP, and the
reaction was found to be reversible. Therefore, the reaction can
be written as
seryl-tRNA[Ser]Sec  ATP
PSTK, Mg2
O-phosphoseryl-tRNA[Ser]Sec  ADP.
In a binding assay, either tRNA[Ser]Sec or seryl-tRNA[Ser]Sec bound
to PSTK, but inclusion of ATP with the two tRNA substrates
had different effects. ATP appeared to enhance the binding of
tRNA[Ser]Sec but decrease the binding of seryl-tRNA[Ser]Sec. The
decreased binding of seryl-tRNA[Ser]Sec was likely due to its con-
version to phosphoseryl-tRNA[Ser]Sec, which was found to have low
affinity for PSTK. Interestingly, tRNA[Ser]Sec was a potent inhibitor
of the phosphorylation reaction, and although the significance of
this inhibition is unclear, PSTK will likely be inhibited significantly
when selenoprotein biosynthesis is down-regulated and the unacy-
lated Sec isoforms are enriched.
PSTK has been highly conserved in evolution in genomes that
encode the machinery for Sec insertion into protein, because it was
found in archaea and numerous lower and higher animals contain-
ing this machinery. What, then, is the possible role of PSTK and
phosphoseryl-tRNA[Ser]Sec in cellular metabolism? It has been
speculated that phosphoseryl-tRNA[Ser]Sec may serve as ‘‘an active
storage form’’ which can, after its dephosphorylation, be regener-
ated as seryl-tRNA[Ser]Sec for the biosynthesis of Sec (27). Several
lines of evidence argue against this proposal. For example, the poor
rate of dephosphorylation of phosphoseryl-tRNA[Ser]Sec by PSTK
observed in the present study suggests that the phosphate group
cannot readily be removed, as has similarly been found for other
kinases, unless the unlikely possibility of a specific phosphatase
might exist. Furthermore, seryl-tRNA[Ser]Sec is an authentic sup-
pressor tRNA that decodes UGA stop codons in vivo (28), and
phosphoseryl-tRNA[Ser]Sec is capable of decoding UGA in vitro
(29), suggesting that these forms of tRNA[Ser]Sec are likely main-
tained intracellularly only transiently as substrates for other reac-
tions. Seryl-tRNA[Ser]Sec is a substrate for PSTK, and if the product
of this reaction is not an intermediate in the biosynthesis of Sec,
then seryl-tRNA[Ser]Sec would also be used in Sec biosynthesis by
another route. In any case, it is easy to visualize that seryl-
tRNA[Ser]Sec is, and must be, ephemeral.
The fact that PSTK has been conserved in evolution as one of
the components of the Sec insertion machinery also strongly
argues that it must play an important role in Sec incorporation
into protein and that it has not been conserved solely for
converting seryl-tRNA[Ser]Sec to a storage form. If phosphoseryl-
tRNA[Ser]Sec is used ephemerally, as proposed above for seryl-
tRNA[Ser]Sec, then it would most likely be used as an intermediate
in the biosynthesis of Sec (reviewed in ref. 2). Indeed, the
phosphate moiety of phosphoseryl-tRNA[Ser]Sec would make an
excellent leaving group for replacement with selenium. If it is an
intermediate in the biosynthesis of Sec, then it, too, would likely
exist only ephemerally intracellularly. In the event phosphoseryl-
tRNA[Ser]Sec is not an intermediate in the biosynthesis of Sec, and
if it does not exist as a storage form for Sec-tRNA[Ser]Sec,
additional hypotheses must be advanced to address its function.
Like the serylated form of tRNA[Ser]Sec (6), phosphoseryl-
tRNA[Ser]Sec does not bind to EFsec (Z. Stoytcheva and M.J.B.,
unpublished work), and, therefore, it cannot be used directly in
incorporating phosphoserine into protein through EFsec and
UGA. Although several important steps in the identity and
characterization of pstk and PSTK have been carried out in the
present study, the function of this kinase and its biosynthetic
product, phosphoseryl-tRNA[Ser]Sec, must await future studies.
This paper is dedicated to the memory of Merton R. Bernfield, April 9,
1939 –March 18, 2002, who originally detected phosphoseryl-
tRNA[Ser]Sec kinase activity in 1970. This work was funded in part by
National Institutes of Health Grant GM061603 (to V.N.G.).
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